Video Experimental Relacionado

Updated: Jul 17, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

La enfermedad de Huntington

Francis O Walker¹

¹Department of Neurology, Wake Forest University, Medical Center Blvd, Winston Salem, NC 27157, USA. fwalker@wfubmc.edu

Lancet (London, England)

|January 24, 2007

Resumen

La enfermedad de Huntington es un trastorno neurodegenerativo progresivo causado por una ganancia tóxica de la función de la proteína huntingtina mutante. La investigación en modelos animales está descubriendo factores causales y tratamientos potenciales para esta condición.

Área de la Ciencia:

La neurociencia es la neurociencia.
Genética La genética.
Biología Molecular Biología Molecular

Sus antecedentes:

La enfermedad de Huntington (HD) es un trastorno neurodegenerativo autosómico dominante.
Se presenta con déficits motores (corea, distonía), deterioro cognitivo y cambios de comportamiento.
El inicio de los síntomas suele ocurrir en la mediana edad, después de los años reproductivos.

Objetivo del estudio:

Comprender los mecanismos fisiopatológicos de la enfermedad de Huntington.
Para investigar el papel de la proteína huntingtina mutante y su tracto poliglutamínico.
Para explorar posibles objetivos terapéuticos utilizando modelos animales.

Principales métodos:

Utilizando modelos animales transgénicos de la enfermedad de Huntington.
Analizando los efectos de la repetición CAG expandida y el tracto poliglutamínico en el huntingtin.
Investigando el mecanismo tóxico de ganancia de función.

Principales resultados:

La proteína huntingtina mutada, resultante de una repetición CAG expandida, conduce a una hebra de poliglutamina.
Este tracto poliglutamínico está implicado en un mecanismo tóxico de ganancia de función.
Los modelos animales transgénicos proporcionan información sobre la causalidad de las enfermedades.

Conclusiones:

Los mecanismos fisiopatológicos precisos de la enfermedad de Huntington todavía están bajo investigación.
La investigación en modelos animales es crucial para comprender los factores causales.
Estos modelos ofrecen una plataforma para desarrollar tratamientos potenciales para la enfermedad de Huntington.

Más Videos Relacionados

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

Videos de Conceptos Relacionados

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Genetic Lingo

Genetic Lingo